trial · primary record
JNJ-69086420
Prostatic Neoplasms
| Phase | Phase 1 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 144 |
| Primary completion | 2026-12-30 |
| Primary endpoint | Number of Participants with Adverse Events (AEs) as a Measure of Safety and Tolerability |
| Registry ID | NCT04644770 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:54.005Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04644770
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.